“Biomarker-Guided Drug Repurposing and Molecular Validation of Angiotensin-2 Receptor Type-1 in Brain Tumor” (2023) Precision Medicine Communications, 3(1), pp. 27–42. doi:10.55627/pmc.003.01.0296.